Home

sottomarino olio Rigenerazione bio rad laboratories inc investor relations Charles Keasing Felce autista

Bio-Rad Laboratories, Inc. - Financials - Financial Results
Bio-Rad Laboratories, Inc. - Financials - Financial Results

Bio-Rad Laboratories, Inc. - Financials - Financial Results
Bio-Rad Laboratories, Inc. - Financials - Financial Results

Leading Life Science Research & Clinical Diagnostics — Bio-Rad
Leading Life Science Research & Clinical Diagnostics — Bio-Rad

Bio-Rad Laboratories, Inc. - Financials - Financial Results
Bio-Rad Laboratories, Inc. - Financials - Financial Results

Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results |  Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results | Business Wire

December 2020 Update FINAL
December 2020 Update FINAL

Bio-Rad Laboratories, Inc. - Financials - Financial Results
Bio-Rad Laboratories, Inc. - Financials - Financial Results

Leading Life Science Research & Clinical Diagnostics — Bio-Rad
Leading Life Science Research & Clinical Diagnostics — Bio-Rad

Leading Life Science Research & Clinical Diagnostics — Bio-Rad
Leading Life Science Research & Clinical Diagnostics — Bio-Rad

EX-99.1
EX-99.1

December 2020 Update FINAL
December 2020 Update FINAL

Corporate Facts | Bio-Rad
Corporate Facts | Bio-Rad

Bio-Rad Laboratories - Crunchbase Company Profile & Funding
Bio-Rad Laboratories - Crunchbase Company Profile & Funding

Bio-Rad Laboratories: More Growth Ahead (NYSE:BIO) | Seeking Alpha
Bio-Rad Laboratories: More Growth Ahead (NYSE:BIO) | Seeking Alpha

Bio-Rad Will Grow In 2020 But Won't Match This Year's Stock Price Gains  (NYSE:BIO) | Seeking Alpha
Bio-Rad Will Grow In 2020 But Won't Match This Year's Stock Price Gains (NYSE:BIO) | Seeking Alpha

investor-relations-feature.jpg
investor-relations-feature.jpg

Bio-Rad Laboratories, Inc. - Investor Relations
Bio-Rad Laboratories, Inc. - Investor Relations

Bio-Rad Laboratories, Inc. - Financials - Financial Results
Bio-Rad Laboratories, Inc. - Financials - Financial Results

Bio-Rad Laboratories: More Growth Ahead (NYSE:BIO) | Seeking Alpha
Bio-Rad Laboratories: More Growth Ahead (NYSE:BIO) | Seeking Alpha

Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022  | Bio-Rad
Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022 | Bio-Rad

December 2020 Update FINAL
December 2020 Update FINAL

BIO-RAD LABORATORIES, INC. General Corporate Statement (Form8) - Benzinga
BIO-RAD LABORATORIES, INC. General Corporate Statement (Form8) - Benzinga

December 2020 Update FINAL
December 2020 Update FINAL

Leading Life Science Research & Clinical Diagnostics — Bio-Rad
Leading Life Science Research & Clinical Diagnostics — Bio-Rad

Bio-Rad Offers Value If You Look (NYSE:BIO) | Seeking Alpha
Bio-Rad Offers Value If You Look (NYSE:BIO) | Seeking Alpha

Bio-Rad Labs (BIO) Investor Presentation - Slideshow (NYSE:BIO) | Seeking  Alpha
Bio-Rad Labs (BIO) Investor Presentation - Slideshow (NYSE:BIO) | Seeking Alpha

Relações com investidor | Bio-Rad
Relações com investidor | Bio-Rad

Bio-Rad Launches the SEQuoia RiboDepletion Kit for Next-Generation  Sequencing | Bio-Rad
Bio-Rad Launches the SEQuoia RiboDepletion Kit for Next-Generation Sequencing | Bio-Rad